Candida albicans Biofilms and Human Disease

Annual Review of Microbiology

Volumn 69, Issue 1, 2015, Pages 71-92

  Nobile, Clarissa J ^a   Johnson, Alexander D ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Fungi; Infection; Microbial community; Microbiota; Pathogen; Transcriptional regulation

Indexed keywords

ANTIFUNGAL AGENT;

ANTIFUNGAL RESISTANCE; ASCOMYCETES; BIOFILM; CANDIDA ALBICANS; CANDIDIASIS; DISPERSION; EXTRACELLULAR MATRIX; FUNGAL GENETICS; FUNGAL PHENOMENA AND FUNCTIONS; FUNGUS GROWTH; FUNGUS HYPHAE; GENETIC REGULATION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MICROBIAL ADHESION; NONHUMAN; PERSISTER CELL; PRIORITY JOURNAL; REVIEW; YEAST CELL; ANIMAL; CELL ADHESION; CLASSIFICATION; CYTOLOGY; FUNGUS; GROWTH, DEVELOPMENT AND AGING; MICROBIOLOGY; MYCOSIS; PATHOLOGY; PHYSIOLOGY;

ANIMALS; BIOFILMS; CANDIDA ALBICANS; CANDIDIASIS; CELL ADHESION; FUNGI; HUMANS; MYCOSES;

EID: 84945274305     PISSN: 00664227     EISSN: 15453251     Source Type: Book Series    
DOI: 10.1146/annurev-micro-091014-104330     Document Type: Review

References (213)

1. Achkar JM, Fries BC. 2010. Candida infections of the genitourinary tract. Clin. Microbiol. Rev. 23: 253-73
2. Al-Fattani MA, Douglas LJ. 2006. Biofilm matrix of Candida albicans and Candida tropicalis: chemical composition and role in drug resistance. J. Med. Microbiol. 55: 999-1008
3. Alabadi D, Oyama T, Yanovsky MJ, Harmon FG, Mas P, Kay SA. 2001. Reciprocal regulation between TOC1 and LHY/CCA1 within the Arabidopsis circadian clock. Science 293: 880-83
4. Anderson JB. 2005. Evolution of antifungal-drug resistance: mechanisms and pathogen fitness. Nat. Rev. Microbiol. 3: 547-56
5. Andes D, Nett J, Oschel P, Albrecht R, Marchillo K, Pitula A. 2004. Development and characterization of an in vivo central venous catheter Candida albicans biofilm model. Infect. Immun. 72: 6023-31
6. Andes DR, Safdar N, Baddley JW, Playford G, Reboli AC, et al. 2012. Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: A patient-level quantitative review of randomized trials. Clin. Infect. Dis. 54: 1110-22
7. Angiolella L, Stringaro AR, De Bernardis F, Posteraro B, Bonito M, et al. 2008. Increase of virulence and its phenotypic traits in drug-resistant strains of Candida albicans. Antimicrob. Agents Chemother. 52: 927-36
8. Askew C, Sellam A, Epp E, Mallick J, Hogues H, et al. 2011. The zinc cluster transcription factor Ahr1p directs Mcm1p regulation of Candida albicans adhesion. Mol. Microbiol. 79: 940-53
9. Bachmann SP, VandeWalle K, Ramage G, Patterson TF, Wickes BL, et al. 2002. In vitro activity of caspofungin against Candida albicans biofilms. Antimicrob. Agents Chemother. 46: 3591-96
10. Baillie GS, Douglas LJ. 1999. Role of dimorphism in the development of Candida albicans biofilms. J. Med. Microbiol. 48: 671-79
11. Baillie GS, Douglas LJ. 2000. Matrix polymers of Candida biofilms and their possible role in biofilm resistance to antifungal agents. J. Antimicrob. Chemother. 46: 397-403
12. BamfordCV, d'Mello A, Nobbs AH, Dutton LC, Vickerman MM, JenkinsonHF. 2009. Streptococcus gordonii modulates Candida albicans biofilm formation through intergeneric communication. Infect. Immun. 77: 3696-704
13. BandaraHM, Yau JY, Watt RM, Jin LJ, SamaranayakeLP. 2009. Escherichia coli and its lipopolysaccharide modulate in vitro Candida biofilm formation. J. Med. Microbiol. 58: 1623-31
14. Bernardo SM, Khalique Z, Kot J, Jones JK, Lee SA. 2008. Candida albicans VPS1 contributes to protease secretion, filamentation, and biofilm formation. Fungal Genet. Biol. 45: 861-77
15. Bernardo SM, Lee SA. 2010. Candida albicans SUR7 contributes to secretion, biofilm formation, and macrophage killing. BMC Microbiol. 10: 133
16. Birrenbach T, Bertschy S, Aebersold F, Mueller NJ, Achermann Y, et al. 2012. Emergence of Blastoschizomyces capitatus yeast infections, Central Europe. Emerg. Infect. Dis. 18: 98-101
17. Bonhomme J, Chauvel M, Goyard S, Roux P, Rossignol T, d'Enfert C. 2011. Contribution of the glycolytic flux and hypoxia adaptation to efficient biofilm formation by Candida albicans. Mol. Microbiol. 80: 995-1013
18. Bonhomme J, d'Enfert C. 2013. Candida albicans biofilms: building a heterogeneous, drug-tolerant environment. Curr. Opin. Microbiol. 16: 398-403
19. Borneman AR, Leigh-Bell JA, Yu H, Bertone P, GersteinM, SnyderM. 2006. Target hub proteins serve as master regulators of development in yeast. Genes Dev. 20: 435-48
20. Bowyer P, Moore CB, Rautemaa R, Denning DW, Richardson MD. 2011. Azole antifungal resistance today: focus on Aspergillus. Curr. Infect. Dis. Rep. 13: 485-91
21. Calderone RA, FonziWA. 2001. Virulence factors of Candida albicans. Trends Microbiol. 9: 327-35
22. Cauda R. 2009. Candidaemia in patients with an inserted medical device. Drugs 69(Suppl. 1): 33-38
23. Chandra J, KuhnDM, Mukherjee PK, Hoyer LL, McCormick T, Ghannoum MA. 2001. Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J. Bacteriol. 183: 5385-94
24. Chang DC, Grant GB, O'Donnell K, Wannemuehler KA, Noble-Wang J, et al. 2006. Multistate outbreak of Fusarium keratitis associated with use of a contact lens solution. JAMA 296: 953-63
25. Chavez-Dozal AA, Jahng M, Rane HS, Asare K, Kulkarny VV, et al. 2014. In vitro analysis of flufenamic acid activity against Candida albicans biofilms. Int. J. Antimicrob. Agents 43: 86-91
26. Chitasombat MN, Kofteridis DP, Jiang Y, Tarrand J, Lewis RE, Kontoyiannis DP. 2012. Rare opportunistic (non-Candida, non-Cryptococcus) yeast bloodstream infections in patients with cancer. J. Infect. 64: 68-75
27. Chitnis AS, Magill SS, Edwards JR, Chiller TM, Fridkin SK, Lessa FC. 2012. Trends in Candida central line-associated bloodstream infections among NICUs, 1999-2009. Pediatrics 130: e46-52
28. Cole MF, Bowen WH, Zhao XJ, Cihlar RL. 1995. Avirulence of Candida albicans auxotrophic mutants in a rat model of oropharyngeal candidiasis. FEMS Microbiol. Lett. 126: 177-80
29. Cornely OA, Bassetti M, Calandra T, Garbino J, Kullberg BJ, et al. 2012. ESCMID guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients. Clin. Microbiol. Infect. 18(Suppl. 7): 19-37
30. Cortez KJ, Roilides E, Quiroz-Telles F, Meletiadis J, Antachopoulos C, et al. 2008. Infections caused by Scedosporium spp. Clin. Microbiol. Rev. 21: 157-97
31. Costerton JW, Cheng KJ, Geesey GG, Ladd TI, Nickel JC, et al. 1987. Bacterial biofilms in nature and disease. Annu. Rev. Microbiol. 41: 435-64
32. Costerton JW, Stewart PS, Greenberg EP. 1999. Bacterial biofilms: A common cause of persistent infections. Science 284: 1318-22
33. Cowen LE. 2008. The evolution of fungal drug resistance: modulating the trajectory from genotype to phenotype. Nat. Rev. Microbiol. 6: 187-98
34. Cruz MR, Graham CE, Gagliano BC, LorenzMC, Garsin DA. 2013. Enterococcus faecalis inhibits hyphal morphogenesis and virulence of Candida albicans. Infect. Immun. 81: 189-200
35. CushionMT, CollinsMS. 2011. Susceptibility of Pneumocystis to echinocandins in suspension and biofilm cultures. Antimicrob. Agents Chemother. 55: 4513-18
36. CushionMT, CollinsMS, LinkeMJ. 2009. Biofilm formation by Pneumocystis spp. Eukaryot. Cell 8: 197-206
37. Daher JY, Koussa J, Younes S, Khalaf RA. 2011. The Candida albicans Dse1 protein is essential and plays a role in cell wall rigidity, biofilm formation, and virulence. Interdiscip. Perspect. Infect. Dis. 2011: 504280
38. D'Antonio D, Mazzoni A, Iacone A, Violante B, Capuani MA, et al. 1996. Emergence of fluconazoleresistant strains of Blastoschizomyces capitatus causing nosocomial infections in cancer patients. J. Clin. Microbiol. 34: 753-55
39. D'Antonio D, Parruti G, Pontieri E, Di Bonaventura G, Manzoli L, et al. 2004. Slime production by clinical isolates of Blastoschizomyces capitatus from patients with hematological malignancies and catheterrelated fungemia. Eur. J. Clin. Microbiol. Infect. 23: 787-89
40. Davis LE, Cook G, Costerton JW. 2002. Biofilm on ventriculo-peritoneal shunt tubing as a cause of treatment failure in coccidioidal meningitis. Emerg. Infect. Dis. 8: 376-79
41. Desai JV, Bruno VM, Ganguly S, Stamper RJ, Mitchell KF, et al. 2013. Regulatory role of glycerol in Candida albicans biofilm formation. mBio 4: e00637-12
42. Desai JV, Mitchell AP, Andes DR. 2014. Fungal biofilms, drug resistance, and recurrent infection. Cold Spring Harb. Perspect. Med. 4: A019729
43. Dominic RM, Shenoy S, Baliga S. 2007. Candida biofilms inmedical devices: evolving trends. Kathmandu Univ. Med. J. 5: 431-36
44. Dongari-Bagtzoglou A, Kashleva H, Dwivedi P, Diaz P, Vasilakos J. 2009. Characterization of mucosal Candida albicans biofilms. PLOS ONE 4: e7967
45. Donlan RM, Costerton JW. 2002. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin. Microbiol. Rev. 15: 167-93
46. Douglas LJ. 2002. Medical importance of biofilms in Candida infections. Rev. Iberoamericana Micol. 19: 139-43
47. Douglas LJ. 2003. Candida biofilms and their role in infection. Trends Microbiol. 11: 30-36
48. Doyle TC, Nawotka KA, Kawahara CB, Francis KP, Contag PR. 2006. Visualizing fungal infections in living mice using bioluminescent pathogenic Candida albicans strains transformed with the firefly luciferase gene. Microb. Pathog. 40: 82-90
49. Dwivedi P, Thompson A, Xie Z, Kashleva H, Ganguly S, et al. 2011. Role of Bcr1-activated genes Hwp1 and Hyr1 in Candida albicans oral mucosal biofilms and neutrophil evasion. PLOS ONE 6: e16218
50. Enache-Angoulvant A, Hennequin C. 2005. Invasive Saccharomyces infection: A comprehensive review. Clin. Infect. Dis. 41: 1559-68
51. Ene IV, Bennett RJ. 2009. Hwp1 and related adhesins contribute to both mating and biofilm formation in Candida albicans. Eukaryot. Cell 8: 1909-13
52. Enjalbert B, Rachini A, VediyappanG, Pietrella D, SpaccapeloR, et al. 2009. Amultifunctional, synthetic Gaussia princeps luciferase reporter for live imaging of Candida albicans infections. Infect. Immun. 77: 4847-58
53. Fader RC, Nunez D, Unbehagen J, Linares HA. 1985. Experimental candidiasis after thermal injury. Infect. Immun. 49: 780-84
54. FalagasME, Betsi GI, Athanasiou S. 2006. Probiotics for prevention of recurrent vulvovaginal candidiasis: A review. J. Antimicrob. Chemother. 58: 266-72
55. Fanning S, Xu W, Beaurepaire C, Suhan JP, Nantel A, Mitchell AP. 2012. Functional control of the Candida albicans cell wall by catalytic protein kinase A subunit Tpk1. Mol. Microbiol. 86: 284-302
56. Ferreira C, Silva S, Faria-Oliveira F, Pinho E, Henriques M, Lucas C. 2010. Candida albicans virulence and drug-resistance requires the O-acyltransferase Gup1p. BMC Microbiol. 10: 238
57. Finkel JS, Xu W, Huang D, Hill EM, Desai JV, et al. 2012. Portrait of Candida albicans adherence regulators. PLOS Pathog. 8: e1002525
58. Fiori A, Kucharikova S, Govaert G, Cammue BP, Thevissen K, Van Dijck P. 2012. The heat-induced molecular disaggregase Hsp104 of Candida albicans plays a role in biofilm formation and pathogenicity in a worm infection model. Eukaryot. Cell 11: 1012-20
59. Fox EP, Bui CK, Nett JE, HartooniN, MuiMM, et al. 2015. An expanded regulatory network temporally controls Candida albicans biofilm formation. Mol. Microbiol. 96: 1226-39
60. Fox EP, Cowley ES, Nobile CJ, Hartooni N, Newman DK, Johnson AD. 2014. Anaerobic bacteria grow within Candida albicans biofilms and induce biofilm formation in suspension cultures. Curr. Biol. 24: 2411-16
61. Fox EP, Nobile CJ. 2012. A sticky situation: untangling the transcriptional network controlling biofilm development in Candida albicans. Transcription 3: 315-22
62. Fridkin SK, Jarvis WR. 1996. Epidemiology of nosocomial fungal infections. Clin. Microbiol. Rev. 9: 499-511
63. Ganguly S, Bishop AC, Xu W, Ghosh S, Nickerson KW, et al. 2011. Zap1 control of cell-cell signaling in Candida albicans biofilms. Eukaryot. Cell 10: 1448-54
64. Ganguly S, Mitchell AP. 2011. Mucosal biofilms of Candida albicans. Curr. Opin. Microbiol. 14: 380-85
65. Garcia MC, Lee JT, Ramsook CB, Alsteens D, Dufrene YF, Lipke PN. 2011. A role for amyloid in cell aggregation and biofilm formation. PLOS ONE 6: e17632
66. Garcia-Sanchez S, Aubert S, Iraqui I, Janbon G, Ghigo JM, d'Enfert C. 2004. Candida albicans biofilms: A developmental state associated with specific and stable gene expression patterns. Eukaryot. Cell 3: 536-45
67. Giacometti R, Kronberg F, Biondi RM, Passeron S. 2011. Candida albicans Tpk1p and Tpk2p isoforms differentially regulate pseudohyphal development, biofilm structure, cell aggregation and adhesins expression. Yeast 28: 293-308
68. Goyard S, Knechtle P, Chauvel M, Mallet A, Prevost MC, et al. 2008. The Yak1 kinase is involved in the initiation and maintenance of hyphal growth in Candida albicans. Mol. Biol. Cell 19: 2251-66
69. Granger BL. 2012. Insight into the antiadhesive effect of yeast wall protein 1 of Candida albicans. Eukaryot. Cell 11: 795-805
70. Granger BL, Flenniken ML, Davis DA, Mitchell AP, Cutler JE. 2005. Yeast wall protein 1 of Candida albicans. Microbiology 151: 1631-44
71. Gutierrez-Escribano P, Zeidler U, Suarez MB, Bachellier-Bassi S, Clemente-Blanco A, et al. 2012. The NDR/LATS kinase Cbk1 controls the activity of the transcriptional regulator Bcr1 during biofilm formation in Candida albicans. PLOS Pathog. 8: e1002683
72. Harriott MM, Lilly EA, Rodriguez TE, Fidel PL Jr, Noverr MC. 2010. Candida albicans forms biofilms on the vaginal mucosa. Microbiology 156: 3635-44
73. Hasan F, Xess I, Wang X, Jain N, Fries BC. 2009. Biofilm formation in clinical Candida isolates and its association with virulence. Microbes Infect. 11: 753-61
74. Hashash R, Younes S, Bahnan W, El Koussa J, Maalouf K, et al. 2011. Characterisation of Pga1, a putative Candida albicans cell wall protein necessary for proper adhesion and biofilm formation. Mycoses 54: 491-500
75. Hawser SP, Douglas LJ. 1994. Biofilm formation by Candida species on the surface of catheter materials in vitro. Infect. Immun. 62: 915-21
76. Hernday AD, Lohse MB, Fordyce PM, Nobile CJ, Derisi JL, Johnson AD. 2013. Structure of the transcriptional network controlling white-opaque switching in Candida albicans. Mol. Microbiol. 90: 22-35
77. Hnisz D, Bardet AF, Nobile CJ, Petryshyn A, Glaser W, et al. 2012. A histone deacetylase adjusts transcription kinetics at coding sequences during Candida albicans morphogenesis. PLOS Genet. 8: e1003118
78. Hogan DA, Vik A, Kolter R. 2004. APseudomonas aeruginosa quorum-sensing molecule influences Candida albicans morphology. Mol. Microbiol. 54: 1212-23
79. Jabra-Rizk MA, FalklerWA, Meiller TF. 2004. Fungal biofilms and drug resistance. Emerg. Infect. Dis. 10: 14-19
80. Jabra-Rizk MA, FalklerWA Jr, Merz WG, Baqui AA, Kelley JI, Meiller TF. 2000. Retrospective identification and characterization of Candida dubliniensis isolates among Candida albicans clinical laboratory isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected individuals. J. Clin. Microbiol. 38: 2423-26
81. Jack AA, Daniels DE, Jepson MA, Vickerman MM, Lamont RJ, et al. 2014. The Streptococcus gordonii comCDE (competence) operonmodulates biofilm formationwith Candida albicans. Microbiology 161: 411-21
82. Jarosz LM, DengDM, van der MeiHC, CrielaardW, Krom BP. 2009. Streptococcus mutans competencestimulating peptide inhibits Candida albicans hypha formation. Eukaryot. Cell 8: 1658-64
83. Johnson C, Kweon HK, Sheidy D, Shively CA, Mellacheruvu D, et al. 2014. The yeast Sks1p kinase signaling network regulates pseudohyphal growth and glucose response. PLOS Genet. 10: e1004183
84. Johnson CC, Yu A, Lee H, Fidel PL Jr, Noverr MC. 2012. Development of a contemporary animal model of Candida albicans-associated denture stomatitis using a novel intraoral denture system. Infect. Immun. 80: 1736-43
85. Kauffman CA. 2007. Histoplasmosis: A clinical and laboratory update. Clin. Microbiol. Rev. 20: 115-32
86. Kelly MT, MacCallum DM, Clancy SD, Odds FC, Brown AJ, Butler G. 2004. The Candida albicans CaACE2 gene affects morphogenesis, adherence and virulence. Mol. Microbiol. 53: 969-83
87. Kennedy MJ, Volz PA. 1985. Ecology of Candida albicans gut colonization: inhibition of Candida adhesion, colonization, and dissemination from the gastrointestinal tract by bacterial antagonism. Infect. Immun. 49: 654-63
88. Khot PD, Suci PA, Miller RL, Nelson RD, Tyler BJ. 2006. A small subpopulation of blastospores in Candida albicans biofilms exhibit resistance to amphotericin B associated with differential regulation of ergosterol and beta-1, 6-glucan pathway genes. Antimicrob. Agents Chemother. 50: 3708-16
89. Kim J, Sudbery P. 2011. Candida albicans, a major human fungal pathogen. J. Microbiol. 49: 171-77
90. Kojic EM, Darouiche RO. 2004. Candida infections of medical devices. Clin. Microbiol. Rev. 17: 255-67
91. Kolter R. 2010. Biofilms in lab and nature: A molecular geneticist's voyage to microbial ecology. Int. Microbiol. 13: 1-7
92. Kolter R, Greenberg EP. 2006. Microbial sciences: The superficial life of microbes. Nature 441: 300-2
93. Krueger KE, Ghosh AK, Krom BP, Cihlar RL. 2004. Deletion of the NOT4 gene impairs hyphal development and pathogenicity in Candida albicans. Microbiology 150: 229-40
94. Kruppa M, Krom BP, Chauhan N, Bambach AV, Cihlar RL, Calderone RA. 2004. The two-component signal transduction proteinChk1p regulates quorum sensing in Candida albicans. Eukaryot. Cell 3: 1062-65
95. Kucharikova S, Tournu H, Lagrou K, Van Dijck P, Bujdakova H. 2011. Detailed comparison of Candida albicans and Candida glabrata biofilms under different conditions and their susceptibility to caspofungin and anidulafungin. J. Med. Microbiol. 60: 1261-69
96. Kullberg BJ, Oude Lashof AM. 2002. Epidemiology of opportunistic invasive mycoses. Eur. J. Med. Res. 7: 183-91
97. Kumamoto CA. 2002. Candida biofilms. Curr. Opin. Microbiol. 5: 608-11
98. Kumamoto CA. 2005. A contact-activated kinase signals Candida albicans invasive growth and biofilm development. PNAS 102: 5576-81
99. Kumamoto CA. 2011. Inflammation and gastrointestinal Candida colonization. Curr. Opin. Microbiol. 14: 386-91
100. LaFleur MD, Kumamoto CA, Lewis K. 2006. Candida albicans biofilms produce antifungal-tolerant persister cells. Antimicrob. Agents Chemother. 50: 3839-46
101. LaFleur MD, Lucumi E, Napper AD, Diamond SL, Lewis K. 2011. Novel high-throughput screen against Candida albicans identifies antifungal potentiators and agents effective against biofilms. J. Antimicrob. Chemother. 66: 820-26
102. LaforetL, Moreno I, Sanchez-FresnedaR, Martinez-EsparzaM, Martinez JP, et al. 2011. Pga26mediates filamentation and biofilm formation and is required for virulence in Candida albicans. FEMS Yeast Res. 11: 389-97
103. Lattif AA, Mukherjee PK, Chandra J, Roth MR, Welti R, et al. 2011. Lipidomics of Candida albicans biofilms reveals phase-dependent production of phospholipid molecular classes and role for lipid rafts in biofilm formation. Microbiology 157: 3232-42
104. Lepak A, Andes D. 2011. Fungal sepsis: optimizing antifungal therapy in the critical care setting. Crit. Care Clin. 27: 123-47
105. Levy B, Heiler D, Norton S. 2006. Report on testing from an investigation of Fusarium keratitis in contact lens wearers. Eye Contact Lens 32: 256-61
106. Li F, Svarovsky MJ, Karlsson AJ, Wagner JP, Marchillo K, et al. 2007. Eap1p, an adhesin that mediates Candida albicans biofilm formation in vitro and in vivo. Eukaryot. Cell 6: 931-39
107. Lin CH, Kabrawala S, Fox EP, Nobile CJ, Johnson AD, Bennett RJ. 2013. Genetic control of conventional and pheromone-stimulated biofilm formation in Candida albicans. PLOS Pathog. 9: e1003305
108. Lindsay AK, Morales DK, Liu Z, Grahl N, Zhang A, et al. 2014. Analysis of Candida albicans mutants defective in the Cdk8 module ofMediator reveal links between metabolism and biofilm formation. PLOS Genet. 10: e1004567
109. Liu G, Vellucci VF, Kyc S, Hostetter MK. 2009. Simvastatin inhibits Candida albicans biofilm in vitro. Pediatr. Res. 66: 600-4
110. Locke JC, Southern MM, Kozma-Bognar L, Hibberd V, Brown PE, et al. 2005. Extension of a genetic network model by iterative experimentation and mathematical analysis. Mol. Syst. Biol. 1: 2005. 0013
111. Lopez D, Vlamakis H, Kolter R. 2010. Biofilms. Cold Spring Harb. Perspect. Biol. 2: A000398
112. Lortholary O, Petrikkos G, Akova M, Arendrup MC, Arikan-Akdagli S, et al. 2012. ESCMID guideline for the diagnosis and management of Candida diseases 2012: Patients with HIV infection or AIDS. Clin. Microbiol. Infect. 18(Suppl. 7): 68-77
113. Marques SA. 2012. Paracoccidioidomycosis. Clin. Dermatol. 30: 610-15
114. Marrie TJ, Costerton JW. 1984. Scanning and transmission electron microscopy of in situ bacterial colonization of intravenous and intraarterial catheters. J. Clin. Microbiol. 19: 687-93
115. Martinez-Gomariz M, Perumal P, Mekala S, Nombela C, ChaffinWL, Gil C. 2009. Proteomic analysis of cytoplasmic and surface proteins from yeast cells, hyphae, and biofilms of Candida albicans. Proteomics 9: 2230-52
116. Martins M, Henriques M, Lopez-Ribot JL, Oliveira R. 2012. Addition of DNase improves the in vitro activity of antifungal drugs against Candida albicans biofilms. Mycoses 55: 80-85
117. Martins M, Uppuluri P, Thomas DP, Cleary IA, Henriques M, et al. 2010. Presence of extracellular DNA in the Candida albicans biofilm matrix and its contribution to biofilms. Mycopathologia 169: 323-31
118. Masala L, Luzzati R, Maccacaro L, Antozzi L, Concia E, Fontana R. 2003. Nosocomial cluster of Candida guillermondii fungemia in surgical patients. Eur. J. Clin. Microbiol. Infect. Dis. 22: 686-88
119. Mateus C, Crow SA Jr, Ahearn DG. 2004. Adherence of Candida albicans to silicone induces immediate enhanced tolerance to fluconazole. Antimicrob. Agents Chemother. 48: 3358-66
120. Melo AS, Padovan AC, Serafim RC, Puzer L, Carmona AK, et al. 2006. The Candida albicans AAA ATPase homologue of Saccharomyces cerevisiae Rix7p (YLL034c) is essential for proper morphology, biofilm formation and activity of secreted aspartyl proteinases. Genet. Mol. Res. 5: 664-87
121. Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, et al. 2009. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin. Infect. Dis. 49: 1-45
122. Mitchell KF, Taff HT, Cuevas MA, Reinicke EL, Sanchez H, Andes DR. 2013. Role of matrix-1, 3 glucan in antifungal resistance of non-albicans Candida biofilms. Antimicrob. Agents Chemother. 57: 1918-20
123. Monniot C, Boisrame A, Da Costa G, Chauvel M, Sautour M, et al. 2013. Rbt1 protein domains analysis in Candida albicans brings insights into hyphal surface modifications and Rbt1 potential role during adhesion and biofilm formation. PLOS ONE 8: e82395
124. Mosci P, Pericolini E, Gabrielli E, Kenno S, Perito S, et al. 2013. A novel bioluminescencemousemodel for monitoring oropharyngeal candidiasis in mice. Virulence 4: 250-54
125. Mowat E, Butcher J, Lang S, Williams C, RamageG. 2007. Development of a simple model for studying the effects of antifungal agents on multicellular communities of Aspergillus fumigatus. J. Med. Microbiol. 56: 1205-12
126. Mukherjee PK, Chandra J, Kuhn DM, Ghannoum MA. 2003. Mechanism of fluconazole resistance in Candida albicans biofilms: Phase-specific role of efflux pumps and membrane sterols. Infect. Immun. 71: 4333-40
127. Mukherjee PK, Mohamed S, Chandra J, Kuhn D, Liu S, et al. 2006. Alcohol dehydrogenase restricts the ability of the pathogen Candida albicans to form a biofilm on catheter surfaces through an ethanol-based mechanism. Infect. Immun. 74: 3804-16
128. Munoz P, BouzaE, Cuenca-Estrella M, Eiros JM, PerezMJ, et al. 2005. Saccharomyces cerevisiae fungemia: An emerging infectious disease. Clin. Infect. Dis. 40: 1625-34
129. Natl. Nosocom. Infect. Surveill. Sys. 2001. National Nosocomial Infections Surveillance (NNIS) System report, data summary from January 1992-June 2001, issued August 2001. Am. J. Infect. Control. 29: 404-21
130. Nett J, Lincoln L, Marchillo K, Massey R, Holoyda K, et al. 2007. Putative role of beta-1, 3 glucans in Candida albicans biofilm resistance. Antimicrob. Agents Chemother. 51: 510-20
131. Nett JE, Brooks EG, Cabezas-Olcoz J, Sanchez H, Zarnowski R, et al. 2014. Rat indwelling urinary catheter model of Candida albicans biofilm infection. Infect. Immun. 82: 4931-40
132. Nett JE, Crawford K, Marchillo K, AndesDR. 2010. Role of Fks1p and matrix glucan in Candida albicans biofilm resistance to an echinocandin, pyrimidine, and polyene. Antimicrob. Agents Chemother. 54: 3505-8
133. Nett JE, Lepak AJ, Marchillo K, Andes DR. 2009. Time course global gene expression analysis of an in vivo Candida biofilm. J. Infect. Dis. 200: 307-13
134. Nett JE, Marchillo K, Spiegel CA, Andes DR. 2010. Development and validation of an in vivo Candida albicans biofilm denture model. Infect. Immun. 78: 3650-59
135. Nett JE, Sanchez H, Cain MT, Andes DR. 2010. Genetic basis of Candida biofilm resistance due to drug-sequestering matrix glucan. J. Infect. Dis. 202: 171-75
136. Nett JE, Sanchez H, Cain MT, Ross KM, Andes DR. 2011. Interface of Candida albicans biofilm matrixassociated drug resistance and cell wall integrity regulation. Eukaryot. Cell 10: 1660-69
137. Ni L, Bruce C, Hart C, Leigh-Bell J, Gelperin D, et al. 2009. Dynamic and complex transcription factor binding during an inducible response in yeast. Genes Dev. 23: 1351-63
138. Nobile CJ, Andes DR, Nett JE, Smith FJ, Yue F, et al. 2006. Critical role of Bcr1-dependent adhesins in C. Albicans biofilm formation in vitro and in vivo. PLOS Pathog. 2: e63
139. Nobile CJ, Fox EP, Hartooni N, Mitchell KF, Hnisz D, et al. 2014. A histone deacetylase complex mediates biofilm dispersal and drug resistance in Candida albicans. mBio 5: e01201-14
140. Nobile CJ, Fox EP, Nett JE, Sorrells TR, Mitrovich QM, et al. 2012. A recently evolved transcriptional network controls biofilm development in Candida albicans. Cell 148: 126-38
141. Nobile CJ, Mitchell AP. 2005. Regulation of cell-surface genes and biofilm formation by the C. Albicans transcription factor Bcr1p. Curr. Biol. 15: 1150-55
142. Nobile CJ, Mitchell AP. 2006. Genetics and genomics of Candida albicans biofilm formation. Cell. Microbiol. 8: 1382-91
143. Nobile CJ, Nett JE, AndesDR, Mitchell AP. 2006. Function of Candida albicans adhesin Hwp1 in biofilm formation. Eukaryot. Cell 5: 1604-10
144. Nobile CJ, Nett JE, Hernday AD, Homann OR, Deneault JS, et al. 2009. Biofilm matrix regulation by Candida albicans Zap1. PLOS Biol. 7: e1000133
145. Nobile CJ, Schneider HA, Nett JE, Sheppard DC, Filler SG, et al. 2008. Complementary adhesin function in C. Albicans biofilm formation. Curr. Biol. 18: 1017-24
146. Norice CT, Smith FJ Jr, Solis N, Filler SG, Mitchell AP. 2007. Requirement for Candida albicans Sun41 in biofilm formation and virulence. Eukaryot. Cell 6: 2046-55
147. Palanisamy SK, Ramirez MA, Lorenz M, Lee SA. 2010. Candida albicans PEP12 is required for biofilm integrity and in vivo virulence. Eukaryot. Cell 9: 266-77
148. Pappas PG, Rex JH, Sobel JD, Filler SG, Dismukes WE, et al. 2004. Guidelines for treatment of candidiasis. Clin. Infect. Dis. 38: 161-89
149. Peltroche-Llacsahuanga H, Goyard S, d'Enfert C, Prill SK, Ernst JF. 2006. Protein Omannosyltransferase isoforms regulate biofilm formation in Candida albicans. Antimicrob. Agents Chemother. 50: 3488-91
150. Perez A, Pedros B, Murgui A, Casanova M, Lopez-Ribot JL, Martinez JP. 2006. Biofilm formation by Candida albicans mutants for genes coding fungal proteins exhibiting the eight-cysteine-containing CFEM domain. FEMS Yeast Res. 6: 1074-84
151. Perlroth J, Choi B, Spellberg B. 2007. Nosocomial fungal infections: epidemiology, diagnosis, and treatment. Med. Mycol. 45: 321-46
152. PfallerMA, Diekema DJ. 2007. Epidemiology of invasive candidiasis: A persistent public health problem. Clin. Microbiol. Rev. 20: 133-63
153. Pietrella D, Enjalbert B, Zeidler U, Znaidi S, Rachini A, et al. 2012. A luciferase reporter for gene expression studies and dynamic imaging of superficial Candida albicans infections. Methods Mol. Biol. 845: 537-46
154. Pitangui NS, Sardi JC, Silva JF, Benaducci T, Moraes da Silva RA, et al. 2012. Adhesion of Histoplasma capsulatum to pneumocytes and biofilm formation on an abiotic surface. Biofouling 28: 711-18
155. Puri S, Kumar R, Chadha S, Tati S, Conti HR, et al. 2012. Secreted aspartic protease cleavage of Candida albicans Msb2 activates Cek1MAPKsignaling affecting biofilm formation and oropharyngeal candidiasis. PLOS ONE 7: e46020
156. Ramage G, Bachmann S, Patterson TF, Wickes BL, Lopez-Ribot JL. 2002. Investigation of multidrug efflux pumps in relation to fluconazole resistance in Candida albicans biofilms. J. Antimicrob. Chemother. 49: 973-80
157. Ramage G, Martinez JP, Lopez-Ribot JL. 2006. Candida biofilms on implanted biomaterials: A clinically significant problem. FEMS Yeast Res. 6: 979-86
158. Ramage G, Mowat E, Jones B, Williams C, Lopez-Ribot J. 2009. Our current understanding of fungal biofilms. Crit. Rev. Microbiol. 35: 340-55
159. Ramage G, Rajendran R, Gutierrez-Correa M, Jones B, Williams C. 2011. Aspergillus biofilms: clinical and industrial significance. FEMS Microbiol. Lett. 324: 89-97
160. Ramage G, Rajendran R, Sherry L, Williams C. 2012. Fungal biofilm resistance. Int. J. Microbiol. 2012: 528521
161. Ramage G, Saville SP, Thomas DP, Lopez-Ribot JL. 2005. Candida biofilms: An update. Eukaryot. Cell 4: 633-38
162. Ramage G, Tomsett K, Wickes BL, Lopez-Ribot JL, Redding SW. 2004. Denture stomatitis: A role for Candida biofilms. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 98: 53-59
163. Ramage G, VandeWalle K, Lopez-Ribot JL, Wickes BL. 2002. The filamentation pathway controlled by the Efg1 regulator protein is required for normal biofilm formation and development in Candida albicans. FEMS Microbiol. Lett. 214: 95-100
164. Reynolds TB, Fink GR. 2001. Bakers' yeast, a model for fungal biofilm formation. Science 291: 878-81
165. Richard ML, Nobile CJ, Bruno VM, Mitchell AP. 2005. Candida albicans biofilm-defective mutants. Eukaryot. Cell 4: 1493-502
166. Ricicova M, Kucharikova S, Tournu H, Hendrix J, Bujdakova H, et al. 2010. Candida albicans biofilm formation in a new in vivo rat model. Microbiology 156: 909-19
167. Robbins N, Uppuluri P, Nett J, Rajendran R, Ramage G, et al. 2011. Hsp90 governs dispersion and drug resistance of fungal biofilms. PLOS Pathog. 7: e1002257
168. Rouabhia M, Semlali A, Chandra J, Mukherjee P, ChmielewskiW, Ghannoum MA. 2012. Disruption of the ECM33 gene in Candida albicans prevents biofilm formation, engineered human oral mucosa tissue damage and gingival cell necrosis/apoptosis. Mediat. Inflamm. 2012: 398207
169. Ryan O, Shapiro RS, Kurat CF, Mayhew D, Baryshnikova A, et al. 2012. Global gene deletion analysis exploring yeast filamentous growth. Science 337: 1353-56
170. Sahni N, Yi S, Daniels KJ, Srikantha T, Pujol C, Soll DR. 2009. Genes selectively up-regulated by pheromone in white cells are involved in biofilm formation in Candida albicans. PLOS Pathog. 5: e1000601
171. Sandini S, Stringaro A, Arancia S, Colone M, Mondello F, et al. 2011. The MP65 gene is required for cell wall integrity, adherence to epithelial cells and biofilm formation in Candida albicans. BMCMicrobiol. 11: 106
172. Sardi JC, Scorzoni L, Bernardi T, Fusco-Almeida AM, Mendes Giannini MJ. 2013. Candida species: current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options. J. Med. Microbiol. 62: 10-24
173. Schinabeck MK, Long LA, Hossain MA, Chandra J, Mukherjee PK, et al. 2004. Rabbit model of Candida albicans biofilm infection: liposomal amphotericin B antifungal lock therapy. Antimicrob. Agents Chemother. 48: 1727-32
174. Schweizer A, Rupp S, Taylor BN, Rollinghoff M, Schroppel K. 2000. The TEA/ATTS transcription factor CaTec1p regulates hyphal development and virulence in Candida albicans. Mol. Microbiol. 38: 435-45
175. Seddiki SM, Boucherit-Otmani Z, Boucherit K, Badsi-Amir S, Taleb M, Kunkel D. 2013. Assessment of the types of catheter infectivity caused by Candida species and their biofilm formation: first study in an intensive care unit in Algeria. Int. J. Gen. Med. 6: 1-7
176. Seidler MJ, Salvenmoser S, Muller FM. 2008. Aspergillus fumigatus forms biofilms with reduced antifungal drug susceptibility on bronchial epithelial cells. Antimicrob. Agents Chemother. 52: 4130-36
177. Sellam A, Al-Niemi T, McInnerney K, Brumfield S, Nantel A, Suci PA. 2009. A Candida albicans early stage biofilm detachment event in rich medium. BMC Microbiol. 9: 25
178. Sellam A, Askew C, Epp E, Tebbji F, Mullick A, et al. 2010. Role of transcription factor CaNdt80p in cell separation, hyphal growth, and virulence in Candida albicans. Eukaryot. Cell 9: 634-44
179. SenM, Shah B, Rakshit S, Singh V, Padmanabhan B, et al. 2011. UDP-glucose 4, 6-dehydratase activity plays an important role in maintaining cell wall integrity and virulence of Candida albicans. PLOS Pathog. 7: e1002384
180. Shah AH, Singh A, Dhamgaye S, Chauhan N, Vandeputte P, et al. 2014. Novel role of a family of major facilitator transporters in biofilm development and virulence of Candida albicans. Biochem. J. 460: 223-35
181. Shapiro RS, Uppuluri P, Zaas AK, Collins C, Senn H, et al. 2009. Hsp90 orchestrates temperaturedependent Candida albicans morphogenesis via Ras1-PKA signaling. Curr. Biol. 19: 621-29
182. Singh V, Satheesh SV, Raghavendra ML, Sadhale PP. 2007. The key enzyme in galactose metabolism, UDP-galactose-4-epimerase, affects cell-wall integrity and morphology in Candida albicans even in the absence of galactose. Fungal Genet. Biol. 44: 563-74
183. Srikantha T, Daniels KJ, Pujol C, Kim E, Soll DR. 2013. Identification of genes upregulated by the transcription factor Bcr1 that are involved in impermeability, impenetrability, and drug resistance of Candida albicans a/biofilms. Eukaryot. Cell 12: 875-88
184. SrikanthaT, Daniels KJ, Pujol C, Sahni N, Yi S, Soll DR. 2012. Nonsex genes in the mating type locus of Candida albicans play roles in a/biofilm formation, including impermeability and fluconazole resistance. PLOS Pathog. 8: e1002476
185. Srinivasan A, Gupta CM, Agrawal CM, Leung KP, Lopez-Ribot JL, Ramasubramanian AK. 2014. Drug susceptibility of matrix-encapsulated Candida albicans nano-biofilms. Biotechnol. Bioeng. 111: 418-24
186. Strijbis K, van Roermund CW, Visser WF, Mol EC, van den Burg J, et al. 2008. Carnitine-dependent transport of acetyl coenzyme A in Candida albicans is essential for growth on nonfermentable carbon sources and contributes to biofilm formation. Eukaryot. Cell 7: 610-18
187. Sullivan DJ, Westerneng TJ, Haynes KA, Bennett DE, Coleman DC. 1995. Candida dubliniensis sp. Nov.: Phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individuals. Microbiology 141(Part 7): 1507-21
188. Sun X, Lu H, Jiang Y, Cao Y. 2013. CaIPF19998 reduces drug susceptibility by enhancing the ability of biofilm formation and regulating redox homeostasis in Candida albicans. Curr. Microbiol. 67: 322-26
189. Taff HT, Nett JE, Zarnowski R, Ross KM, Sanchez H, et al. 2012. A Candida biofilm-induced pathway for matrix glucan delivery: implications for drug resistance. PLOS Pathog. 8: e1002848
190. Tan X, Fuchs BB, Wang Y, Chen W, Yuen GJ, et al. 2014. The role of Candida albicans SPT20 in filamentation, biofilm formation and pathogenesis. PLOS ONE 9: e94468
191. Thomas DP, Bachmann SP, Lopez-Ribot JL. 2006. Proteomics for the analysis of the Candida albicans biofilm lifestyle. Proteomics 6: 5795-804
192. Thomas DP, Lopez-Ribot JL, Lee SA. 2009. A proteomic analysis of secretory proteins of a pre-vacuolar mutant of Candida albicans. J. Proteomics 73: 342-51
193. Tsai PW, Chen YT, Yang CY, Chen HF, Tan TS, et al. 2014. The role of Mss11 in Candida albicans biofilm formation. Mol. Genet. Genomics 289: 807-19
194. Uppuluri P, Chaturvedi AK, Srinivasan A, Banerjee M, Ramasubramaniam AK, et al. 2010. Dispersion as an important step in the Candida albicans biofilm developmental cycle. PLOS Pathog. 6: e1000828
195. Uppuluri P, Pierce CG, Thomas DP, Bubeck SS, Saville SP, Lopez-Ribot JL. 2010. The transcriptional regulator Nrg1p controls Candida albicans biofilm formation and dispersion. Eukaryot. Cell 9: 1531-37
196. UwamahoroN, Qu Y, Jelicic B, Lo TL, Beaurepaire C, et al. 2012. The functions of Mediator in Candida albicans support a role in shaping species-specific gene expression. PLOS Genet. 8: e1002613
197. Vande VeldeG, Kucharikova S, Schrevens S, Himmelreich U, Van Dijck P. 2014. Towards non-invasive monitoring of pathogen-host interactions during Candida albicans biofilm formation using in vivo bioluminescence. Cell. Microbiol. 16: 115-30
198. Vande VeldeG, Kucharikova S, Van Dijck P, Himmelreich U. 2014. Bioluminescence imaging of fungal biofilm development in live animals. Methods Mol. Biol. 1098: 153-67
199. Wang X, Fries BC. 2011. Amurinemodel for catheter-associated candiduria. J. Med. Microbiol. 60: 1523-29
200. Watanabe NA, Miyazaki M, Horii T, Sagane K, Tsukahara K, Hata K. 2012. E1210, a new broadspectrum antifungal, suppresses Candida albicans hyphal growth through inhibition of glycosylphosphatidylinositol biosynthesis. Antimicrob. Agents Chemother. 56: 960-71
201. Weig M, Gross U, Muhlschlegel F. 1998. Clinical aspects and pathogenesis of Candida infection. Trends Microbiol. 6: 468-70
202. Wenzel RP. 1995. Nosocomial candidemia: risk factors and attributable mortality. Clin. Infect. Dis. 20: 1531-34
203. Wilson NK, Foster SD, Wang X, Knezevic K, Schutte J, et al. 2010. Combinatorial transcriptional control in blood stem/progenitor cells: genome-wide analysis of ten major transcriptional regulators. Cell Stem Cell 7: 532-44
204. WisplinghoffH, BischoffT, Tallent SM, Seifert H, Wenzel RP, EdmondMB. 2004. Nosocomial bloodstream infections in US hospitals: Analysis of 24, 179 cases from a prospective nationwide surveillance study. Clin. Infect. Dis. 39: 309-17
205. Yeater KM, Chandra J, Cheng G, Mukherjee PK, Zhao X, et al. 2007. Temporal analysis of Candida albicans gene expression during biofilm development. Microbiology 153: 2373-85
206. Young RA. 2011. Control of the embryonic stem cell state. Cell 144: 940-54
207. Yu Q, Wang F, Zhao Q, Chen J, Zhang B, et al. 2014. A novel role of the vacuolar calcium channel Yvc1 in stress response, morphogenesis and pathogenicity of Candida albicans. Int. J. Med. Microbiol. 304: 339-50
208. Yu Q, Wang H, Xu N, Cheng X, Wang Y, et al. 2012. Spf1 strongly influences calcium homeostasis, hyphal development, biofilm formation and virulence in Candida albicans. Microbiology 158: 2272-82
209. Zarnowski R, Westler WM, Lacmbouh GA, Marita JM, Bothe JR, et al. 2014. Novel entries in a fungal biofilm matrix encyclopedia. mBio 5: e01333-14
210. Zeidler U, Bougnoux ME, Lupan A, Helynck O, Doyen A, et al. 2013. Synergy of the antibiotic colistin with echinocandin antifungals in Candida species. J. Antimicrob. Chemother. 68: 1285-96
211. Zhang X, Sun X, Wang Z, Zhang Y, Hou W. 2012. Keratitis-associated fungi form biofilms with reduced antifungal drug susceptibility. Invest. Ophthalmol. Visual Sci. 53: 7774-78
212. Zhao X, Daniels KJ, Oh SH, Green CB, Yeater KM, et al. 2006. Candida albicans Als3p is required for wild-type biofilm formation on silicone elastomer surfaces. Microbiology 152: 2287-99
213. Zhao X, Oh SH, Yeater KM, Hoyer LL. 2005. Analysis of the Candida albicans Als2p and Als4p adhesins suggests the potential for compensatory function within the Als family. Microbiology 151: 1619-30